Relagesic - 11584-0476-1 - (Acetaminophen and Phenyltoloxamine Citrate)

Alphabetical Index


Drug Information of Relagesic

Product NDC: 11584-0476
Proprietary Name: Relagesic
Non Proprietary Name: Acetaminophen and Phenyltoloxamine Citrate
Active Ingredient(s): 650; 50    mg/1; mg/1 & nbsp;   Acetaminophen and Phenyltoloxamine Citrate
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of Relagesic

Product NDC: 11584-0476
Labeler Name: International Ethical Labs, inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number:
Marketing Category: UNAPPROVED DRUG OTHER
Start Marketing Date: 19950916

Package Information of Relagesic

Package NDC: 11584-0476-1
Package Description: 100 TABLET in 1 BOTTLE, DISPENSING (11584-0476-1)

NDC Information of Relagesic

NDC Code 11584-0476-1
Proprietary Name Relagesic
Package Description 100 TABLET in 1 BOTTLE, DISPENSING (11584-0476-1)
Product NDC 11584-0476
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Acetaminophen and Phenyltoloxamine Citrate
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 19950916
Marketing Category Name UNAPPROVED DRUG OTHER
Labeler Name International Ethical Labs, inc.
Substance Name ACETAMINOPHEN; PHENYLTOLOXAMINE CITRATE
Strength Number 650; 50
Strength Unit mg/1; mg/1
Pharmaceutical Classes

Complete Information of Relagesic


General Information